Subscribe to Newsletter

Business Practice

Business & Regulation Business Practice

Drug Pricing Lawsuits Ramp Up

| Stephanie Vine | 5 min read

More pharma stakeholders are launching lawsuits over the US government’s Inflation Reduction Act.

Discovery & Development Drug Delivery

Revenge of the ADCs

| Stephanie Vine | 15 min read

Are antibody drug conjugates (ADCs) the breakthrough in cancer treatment? Experts share insights on recent advancements

Manufacture Bioprocessing - Upstream & Downstream

Creating for Tomorrow

| Sponsored by Asahi Kasei | 7 min read

We interview Clayton Weber, Systems Engineering Lead/ Sustainability Lead at Asahi Kasei Bioprocess

Business & Regulation Business Practice

Never Break the Chain

| Nadine Lampka | 5 min read

How do we prevent criminals from reusing primary packaging for counterfeit medicines? Labeling solutions and other creative concepts can help.

Manufacture Contract Manufacturing Services

Six of the Best

| 2 min read

Germany-based CDMO Vetter received six nominations in the 2023 CDMO Leadership Awards. Here, Carsten Press shares his thoughts on the achievement.

Business & Regulation Standards & Regulation

MSD Files Lawsuit Against US Government

| Stephanie Vine | 4 min read

MSD describes drug price negotiation program as “sham” and “tantamount to extortion”

Discovery & Development Drug Discovery

Cancer Treatments for Kids

| Jamie Irvine | 5 min read

Day One Bio commits to creating purposeful treatments for children with life-threatening diseases

Business & Regulation Business Practice

What’s Going On With Amgen and Horizon Therapeutics?

| Stephanie Vine | 2 min read

Amgen’s planned acquisition of Horizon Therapeutics has hit a bump in the road.

Discovery & Development Drug Discovery

Cell Therapy Team Up

| Jamie Irvine | 2 min read

Thermo Fisher Scientific and UCSF launch new cell therapy manufacturing site to accelerate advanced cell therapies development

Business & Regulation Business Practice

The Price of the PBM

| Mallikarjun Chityala | 5 min read

There are many players in pharmaceutical pricing, from drug manufacturers to PBMs and pharmacies. Who should take the lead?

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register